Unlock instant, AI-driven research and patent intelligence for your innovation.

Cyano-containing heterocyclic compound and application thereof

A technology of heterocyclic compounds and compounds, applied in the field of biomedicine, can solve the problem of lack of small molecule binding cavities on the surface of KRAS protein, and achieve the effect of excellent cell activity

Pending Publication Date: 2021-06-25
WUHAN YUXIANG PHARM TECH CO LTD
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, due to the lack of good small-molecule binding cavities on the surface of the KRAS protein, the development of small-molecule inhibitors based on KRAS has always been one of the difficulties in the field of medicine. Inhibitors have great clinical value and broad market prospects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cyano-containing heterocyclic compound and application thereof
  • Cyano-containing heterocyclic compound and application thereof
  • Cyano-containing heterocyclic compound and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0084] Embodiment 1: the preparation of the compound shown in formula I-1

[0085]

[0086] synthetic route:

[0087]

[0088] Preparation:

[0089] Step 1: Synthesis of Compound I-1B

[0090] Dissolve the raw material 1-1A (18.6g, 100mmol) in DMF (200mL), then cool to 0 to 5 degrees, add NaH (10g, 150mmol) with a mass fraction of 60% in batches, and react at room temperature after the addition 1 hour, then cooled to 0 to 5 degrees again, the DMF solution (10ml) of cyanoacetyl chloride (10.3g, 100mmol) was added dropwise, and after the dropwise addition, the room temperature was reacted for 4 hours. After TLC showed that the reaction was over, the reaction solution was added to In ice water (800mL), adjust the pH to 4-5 with 1M hydrochloric acid, extract the aqueous phase with ethyl acetate (300ml*2), combine the organic phases, wash with saturated sodium chloride solution, and dry the organic phases with anhydrous sodium sulfate , and the obtained residue was spin-dr...

Embodiment 2

[0114] Embodiment 2 Pharmacodynamics detection experiment

[0115] Determination of the activity of the compound of the present invention on highly expressed KRAS G12C human non-small cell lung cancer cell NCI-H358 and human pancreatic cancer cell Mia Paca-2

[0116] The following methods were used to determine the effect of compounds of the present invention on tumor cell proliferation.

[0117] For the KRAS G12C subtype, the highly expressed KRAS G12C human non-small cell lung cancer cell NCI-H358 and the human pancreatic cancer cell Mia Paca-2 were used to test the anti-cancer activity of the compound. The NCI-H358 cells were cultured in 10% fetal bovine serum , 100 U penicillin and 100 μg / mL streptomycin in DMEM medium. Culture at 37 degrees 5% CO 2 Inside the incubator. Cancer cell activity through the use of Cell The kit (Luminescent Cell Viability Assay kit, refer to the manufacturer's instructions for usage) was used to measure the content of ATP to evaluate cell ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a cyano-containing heterocyclic compound and uses thereof. The cyano-containing heterocyclic compound is a compound represented by formula I, or a pharmaceutically acceptable salt thereof, or a stereoisomer thereof, or a tautomer thereof, or a hydrate thereof, or a solvate thereof, or a metabolite thereof, or a prodrug thereof, wherein R1-R2 and X, A, E, L and K groups are defined in the specification. The compound provided by the invention can be used for preparing medicines for treating and / or preventing cancers.

Description

technical field [0001] The invention belongs to the technical field of biomedicine, and relates to a cyano-heterocyclic compound and its application. Background technique [0002] In the field of cancer research, KRAS is one of the most well-known oncogenes. Oncogene RAS frequently mutates in human tumors, accounting for about one-third of all human malignant tumor mutations. The RAS family includes HRAS, NRAS and KRAS. As the main subtype of the RAS protein family, KRAS mutations account for 86% of all RAS protein mutations, and are more common in pancreatic cancer, colorectal cancer and lung cancer. In non-small cell lung cancer (NSCLC), 15% to 30% of patients have KRAS gene mutation, of which lung adenocarcinoma accounts for 30% to 50%, which is higher than EGFR, ALK, etc.; the probability of abnormal KRAS gene mutation in colorectal cancer patients is 30% %-35%; In pancreatic cancer, more than 90% of patients have KRAS mutations. The KRAS signaling pathway is an impor...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D471/04C07D519/00A61K31/496A61K31/4725A61P35/00
CPCC07D471/04C07D519/00A61P35/00
Inventor 方华祥张晓林刘呈祥陶进峰
Owner WUHAN YUXIANG PHARM TECH CO LTD